Cyxone investor relations material

Cyxone AB (publ) is a clinical biotech company focusing on the development of new therapies to treat autoimmune diseases and acute respiratory disorders. The company's lead products include Cyxonexim (rheumatoid arthritis), and Cyxonidexim (multiple sclerosis).